Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
21262 | 366 | 22.3 | 59% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
1619 | 6500 | ESSENTIAL THROMBOCYTHEMIA//POLYCYTHEMIA VERA//MYELOFIBROSIS |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | CHRONIC NEUTROPHILIC LEUKEMIA | Author keyword | 50 | 75% | 10% | 36 |
2 | CHRONIC NEUTROPHILIC LEUKAEMIA | Author keyword | 11 | 100% | 2% | 6 |
3 | COLONY STIMULATING FACTOR 3 RECEPTOR MUTATION | Author keyword | 2 | 67% | 1% | 2 |
4 | LEUKAEMIA LYMPHOMA MOL HEMATOL UNIT | Address | 2 | 67% | 1% | 2 |
5 | CHRONIC NEUTROPHILIC LEUKEMIA CNL | Author keyword | 1 | 50% | 1% | 2 |
6 | LEUKAEMOID REACTION | Author keyword | 1 | 50% | 1% | 2 |
7 | SETBP1 | Author keyword | 1 | 33% | 1% | 3 |
8 | CNL | Author keyword | 1 | 25% | 1% | 4 |
9 | ATYPICAL CHRONIC MYELOID LEUKAEMIA | Author keyword | 1 | 40% | 1% | 2 |
10 | HEMATOL CLIN UNIT | Address | 1 | 33% | 1% | 2 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | GENOMIC EVENTS | 6 | 80% | 1% | 4 |
2 | DYSPLASTIC FEATURES | 6 | 71% | 1% | 5 |
3 | INDEPENDENT CLONAL EVOLUTION | 6 | 100% | 1% | 4 |
4 | CHRONIC LYMPHATIC LEUKEMIA | 3 | 21% | 3% | 11 |
5 | CHRONIC NEUTROPHILIC LEUKEMIA | 2 | 18% | 3% | 11 |
6 | CSF3R | 1 | 100% | 1% | 2 |
7 | SYNDROME COEXISTENT | 1 | 100% | 1% | 2 |
8 | MARROW FIBROSIS | 1 | 17% | 2% | 6 |
9 | CSF3R MUTATIONS | 1 | 23% | 1% | 3 |
10 | SETBP1 MUTATIONS | 1 | 21% | 1% | 3 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references |
% act. ref. to same field |
---|---|---|---|---|
The molecular genetics of chronic neutrophilic leukaemia: defining a new era in diagnosis and therapy | 2014 | 3 | 44 | 61% |
A Rare Patient with Chronic Myeloid Leukemia and Chronic Lymphocytic Leukemia | 2008 | 13 | 19 | 68% |
Chronic neutrophilic leukaemia: A distinct clinical entity? | 2002 | 37 | 72 | 54% |
Chronic neutrophilic leukemia (CNL): a clinical, pathologic and cytogenetic study | 2001 | 29 | 15 | 80% |
Chronic neutrophilic leukemia and chronic myelomonocytic leukemia: WHO defined | 2006 | 19 | 91 | 30% |
Chronic neutrophilic leukaemia | 2015 | 0 | 34 | 79% |
Chronic lymphocytic leukemia developing in a case of chronic myelogenous leukemia - accelerated phase: A rare case with review of the literature | 2013 | 2 | 7 | 71% |
JAK2 Mutation-Negative Secondary Erythrocytosis in Smoldering Plasma Cell Myeloma: A Case Study and Review of the Literature | 2011 | 0 | 5 | 80% |
Current strategies in the diagnosis and management of chronic neutrophilic leukemia | 2014 | 0 | 14 | 64% |
Concomitant primary polycythemia vera and follicle center cell non-Hodgkin lymphoma: A case report and review of literature | 2002 | 6 | 23 | 48% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | LEUKAEMIA LYMPHOMA MOL HEMATOL UNIT | 2 | 67% | 0.5% | 2 |
2 | HEMATOL CLIN UNIT | 1 | 33% | 0.5% | 2 |
3 | IMMUNOTRANSFUS UNIT | 1 | 50% | 0.3% | 1 |
4 | NEBRASKA MED 982055 | 1 | 50% | 0.3% | 1 |
5 | ONCOL HEMATOL TRANSPLANTAT | 1 | 50% | 0.3% | 1 |
6 | SECTOR 32A | 1 | 50% | 0.3% | 1 |
7 | SPITALUL CLIN JUDETEAN URGENTA TG MU | 1 | 50% | 0.3% | 1 |
8 | U124 INSERM | 1 | 50% | 0.3% | 1 |
9 | PATHOL LUDWIG A OFF HAUS | 0 | 33% | 0.3% | 1 |
10 | LUDWIG A OFF HAUS | 0 | 25% | 0.3% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000172073 | RICHTERS SYNDROME//RICHTER SYNDROME//COMPOSITE LYMPHOMA |
2 | 0.0000119888 | ESSENTIAL THROMBOCYTHEMIA//POLYCYTHEMIA VERA//MYELOFIBROSIS |
3 | 0.0000104124 | SECONDARY LEUKEMIA//SECOND MALIGNANT NEOPLASM//THERAPY RELATED |
4 | 0.0000079919 | MYELODYSPLASTIC SYNDROMES//MYELODYSPLASTIC SYNDROME//AZACITIDINE |
5 | 0.0000069355 | G CSF PRODUCING TUMOR//LEUKEMOID REACTION//LEUKOCYTOSIS |
6 | 0.0000063958 | PHILADELPHIA CHROMOSOME//CML//CHRONIC MYELOGENOUS LEUKEMIA |
7 | 0.0000062992 | BIOMED 2//TREPHINE BIOPSY//BONE MARROW BIOPSY |
8 | 0.0000057368 | PLASMA CELL LEUKEMIA//PRIMARY PLASMA CELL LEUKEMIA//MMSET |
9 | 0.0000057235 | SEVERE CONGENITAL NEUTROPENIA//HAX 1//CYCLIC NEUTROPENIA |
10 | 0.0000052080 | POEMS SYNDROME//CROW FUKASE SYNDROME//OSTEOSCLEROTIC MYELOMA |